Skip to main content

Joint IOGP-IPIECA position on COVID-19 vaccines

February 2021

Since the beginning of the COVID-19 pandemic, the joint IPIECA-IOGP Health Committee has striven to ensure that the industry was operating with the most up-to-date and scientifically sound information possible when making decisions that affect workers' health during the pandemic.

From late 2020, several COVID-19 vaccines have been approved by regulators in many countries. This document aims to help companies understand these developments, provide guidance for company policy development, and offer an assessment of the expected impact vaccines will have on the course of the pandemic. 

Download now

Select your area of work (required)

Select your region (required)

Thank you for downloading the IPIECA resource(s). If you wish to obtain hard copies, please contact